Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.

Autor: Hamilton, Mark P.1,2,3, Takeshi Sugio1,4, Noordenbos, Troy1,4,5, Shuyu Shi6, Bulterys, Philip L.7, Chih Long Liu1,4, Xiaoman Kang1,4, Olsen, Mari N.1,4, Good, Zinaida3,8, Dahiya, Saurabh2,3, Frank, Matthew j.2,3, Sahaf, Bita3, Mackall, Crystal L.3,4,9, Gratzinger, Dita7, Diehn, Maximilian4,10,11, Alizadeh, Ash A.1,4,11 arasha@stanford.edu, Miklos, David B.2,3,4
Zdroj: New England Journal of Medicine. 6/13/2024, Vol. 390 Issue 22, p2047-2060. 14p.
Databáze: Academic Search Ultimate